http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011000122-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_df7c3369848cf34e3ad13be3ba4980b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_125af8bc9109542a299f3ad0489ea1e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_419133ce0c2f33d6ad257cda480031cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_234f2bfbc074f13e901ae3fcb438cdca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4170a8ce7ab90e114daacd086e51a13e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5057
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5089
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74
filingDate 2010-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47d2e79c8ecde672f21542e338139205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4149b1538fe313dce33e24bbdf1ecdeb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee19d6ca08b38d17ec1bb770f28a7046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d661e911b6273fd4d837b5d1fdbad496
publicationDate 2011-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2011000122-A1
titleOfInvention Formulation based on the synthesis of microspheres made from cross-linked natural gelatine, used as a carrier for strains of probiotic lactobacillus spp. for treating skin wounds and/or lesions
abstract The invention relates to technology comprising a probiotic formulation for topical use which includes (1) microspheres with a matrix composition made from cross-linked natural gelatine and (2) a viable probiotic strain of Lactobacillus spp . The invention is characterised mainly in the joint action of the two components, which is essential in order to obtain the intended effect. The invention also relates to a method for generating said microspheres and the use thereof in lesions such as wounds, ulcers, burns and/or surgery, including infected tissues and chronic infections. Said microspheres also have cosmetic and dermatological uses.
priorityDate 2009-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03096823-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005089564-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6190591-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005115341-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7201923-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9638159-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003152629-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003012819-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394197
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405626
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394130
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID103023
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393662
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128244086
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128760372
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10953859
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421593
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56605938
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID798

Total number of triples: 47.